Pharmaceutical Industry Reports Pneumococcal Vaccines Market | Page 2

REPORT DESCRIPTION
Pneumococcal Vaccines Market – Overview
Pneumococcal vaccine is used to prevent infection caused by streptococcus pneumoniae bacteria. There are two
types of pneumococcal vaccines: pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine.
Centers for Disease Control and Prevention (CDC) recommends pneumococcal conjugate vaccine for all
children younger than 2 years old, all adults 65 years or older, and for people 2-64 years old with certain
medical conditions. CDC recommends pneumococcal polysaccharide vaccine for all adults 65 years or older,
people 2-64 years old with certain medical conditions, and adults 19-64 years old who smoke cigarettes.
The global pneumococcal vaccines market size was valued at US$ 7,376.6 million in 2018 and is expected to
witness a CAGR of 7.5% over the forecast period (2018 – 2026).
High mortality due to pneumonia among the global population is expected to increase adoption of
pneumococcal vaccines over the forecast period. For instance, according to the World Health Organization
(WHO) November 2016, pneumonia accounted for 16% of all deaths of children under 5 years old in 2015, with
920,136 deaths globally.
© Coherent market Insights. All Rights Reserved